Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis

Arthritis and Rheumatism

Volumn 43, Issue 6, 2000, Pages 1366-1370

  Martínez, Alfonso ^a   Fernández Arquero, Miguel ^a   Pascual Salcedo, Dora ^b   Conejero, Laura ^a   Alves, Helena ^c   Balsa, Alejandro ^b   De La Concha, Emilio G ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c Ministerio da Saude Portuguese   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ADULT; AGED; ALLELE; AMINO ACID SEQUENCE; ARTICLE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS;

ALLELES; ARTHRITIS, RHEUMATOID; EPITOPES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DR ANTIGENS; HUMANS; LYMPHOTOXIN-ALPHA; MICROSATELLITE REPEATS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 0342732899     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200006)43:6<1366::AID-ANR21>3.0.CO;2-S     Document Type: Article

References (21)

1. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 1978;298:869-71.
2. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30: 1205-13.
3. Weyand CM, Hicock KC, Conn DL, Goronzy JJ. The influence of ULA-DRBI genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992;117:801-6.
4. Boki KA, Panayi GS, Vaughan RW, Drosos AA, Moutsopoulos HM, Lanchbury JS. HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks: the HLA-DRβ shared-epitope hypothesis accounts for the disease in only a minority of Greek patients. Arthritis Rheum 1992;35:749-55.
5. Seldin MF, Amos CI, Ward R, Gregersen PK. The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 1999;42:1071-9.
6. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 1996;85:307-10.
7. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
8. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antonio C, Smolen JJ, et al. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 1994;344:1105-10.
9. Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turetskaya RL. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993;16:180-6.
10. Vinasco J, Beraún A, Nieto A, Fraile A, Mataran L, Pareja E, et al. Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens 1997;49:74-8.
11. Gruen JR, Weissman M. Evolving views of the major histocompatibility complex. Blood 1997;90:4252-65.
12. Field M, Gallagher G, Eskdale J, McGarry SD, Munro R, Oh HH, et al. Tumor necrosis factor locus polymorphisms in rheumatoid arthritis. Tissue Antigens 1997;50:303-7.
13. Mulcahy B, Waldrom-Lynch F, McDermott MF, Adams C, Amos CI, Zhu DK, et al. Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet 1996;59:676-83.
14. Hajeer AH, Worthington J, Silman AJ, Ollier WER. Association of tumor necrosis factor microsatellite polymorphisms with HLA-DRB1*04-bearing haplotypes in rheumatoid arthritis patients. Arthritis Rheum 1996;39:1109-14.
15. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
16. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA typing technique. In: Tsuji K, Aizawa M, Sasazuki T, editors. HLA 1991. Vol. 1. Proceedings of the eleventh International Histocompatibility Workshop and Conference. Oxford: Oxford University Press; 1991. p. 397-419.
17. Brinkman BM, Huizinga TW, Kurban SS, van der Velde EA, Schreuder GM, Hazes JM, et al. Tumor necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol 1997;36:516-21.
18. Thorbecke GJ, Shah R, Leu CH, Kuruvilla AP, Hardison AM, Palladino MA. Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II induced arthritis in mice. Proc Natl Acad Sci USA 1992;89:7375-9.
19. Chaplin DD, Fu Y. Cytokine regulation of secondary lymphoid organ development. Curr Opin Immunol 1998;10:289-97.
20. Klein J, Satta Y, O'Huigin C, Takahata N. The molecular descent of the major histocompatibility complex. Annu Rev Immunol 1993;10:269-95.
21. Mu H, Chen JJ, Jiang Y, King M-C, Thomson G, Criswell LA. Tumor necrosis factor a microsatellite polymorphism is associated with rheumatoid arthritis severity through an interaction with the HLA-DRB1 shared epitope. Arthritis Rheum 1999;42:438-42.